iNtRON Biotechnology, Inc. (KOSDAQ:048530)
 3,320.00
 -55.00 (-1.63%)
  Oct 31, 2025, 3:30 PM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 106.7 billion as of October 31, 2025. Its market cap has decreased by -42.99% in one year.
Market Cap 
 106.70B
Enterprise Value 
 66.36B
Revenue 
 5.14B
Ranking 
 n/a
PE Ratio 
 n/a
Stock Price 
3,320.00
Market Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 106.70B, an increase of 11.96%. That is a compound annual growth rate of 0.77%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 31, 2025 | 104.96B | -42.82% | 
| Dec 30, 2024 | 183.56B | -37.01% | 
| Dec 28, 2023 | 291.42B | 7.98% | 
| Dec 29, 2022 | 269.88B | -61.99% | 
| Dec 30, 2021 | 710.00B | -22.41% | 
| Dec 30, 2020 | 915.06B | 97.15% | 
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | 
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro | 
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro | 
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Samsung Biologics | 87.69T | 
| Celltrion | 39.50T | 
| ALTEOGEN | 25.46T | 
| SK Biopharmaceuticals | 9.08T | 
| Yuhan | 8.94T | 
| HLB Co., Ltd. | 6.25T | 
| Peptron | 6.06T | 
| PharmaResearch | 5.57T |